{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:38:52Z","timestamp":1792427932546,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","award":["RF 14-3-401"],"award-info":[{"award-number":["RF 14-3-401"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","award":["RF 15-3-402"],"award-info":[{"award-number":["RF 15-3-402"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01981","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:56:26Z","timestamp":1566471386000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica"],"prefix":"10.3389","volume":"10","author":[{"given":"Yannick","family":"van Sleen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacoba C.","family":"Graver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayel H.","family":"Abdulahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelis S. M.","family":"van der Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke M. H.","family":"Boots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sandovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/rheumatology\/kew273","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2016","journal-title":"Rheumatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4081\/reumatismo.2018.1048","article-title":"Pathogenesis of polymyalgia rheumatica","volume":"70","author":"Guggino","year":"2018","journal-title":"Reumatismo."},{"key":"B5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","article-title":"Recent advances in our understanding of giant cell arteritis pathogenesis","volume":"16","author":"Samson","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","article-title":"Immune mechanisms in medium and large-vessel vasculitis","volume":"9","author":"Weyand","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/annrheumdis-2016-209217","article-title":"Ectopic expression of CXCL13, BAFF, APRIL and LT-beta is associated with artery tertiary lymphoid organs in giant cell arteritis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211860","article-title":"Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries","volume":"77","author":"Graver","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"van der Geest","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCRESAHA.114.301374","article-title":"Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression","volume":"114","author":"Nadkarni","year":"2014","journal-title":"Circ Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study","volume":"53","author":"Salvarani Carlo","year":"2005","journal-title":"Arthritis Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/kez034","article-title":"Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis","volume":"58","author":"van Sleen","year":"2019","journal-title":"Rheumatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4065\/81.8.1071","article-title":"The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970","volume":"81","author":"Hunder Gene","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2016.05.009","article-title":"Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis","volume":"46","author":"Broder","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/rheumatology\/kex459","article-title":"Prevention of glucocorticoid morbidity in giant cell arteritis","volume":"57","author":"Buttgereit Frank","year":"2018","journal-title":"Rheumatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/art.39740","article-title":"Brief report: a prospective open-label phase IIa trial of tocilizumab in the treatment of polymyalgia rheumatica","volume":"68","author":"Lally","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med."},{"key":"B18","first-page":"121","article-title":"Treatment with methotrexate and risk of relapses in patients with giant cell arteritis in clinical practice","volume":"36","author":"Leon Leticia","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/rheumatology\/key015","article-title":"Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis","volume":"57","author":"Reichenbach","year":"2018","journal-title":"Rheumatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/rheumatology\/key158","article-title":"Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritis","volume":"57","author":"Gloor Andrea","year":"2018","journal-title":"Rheumatology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1093\/rheumatology\/kex424","article-title":"Large-vessel giant cell arteritis: diagnosis, monitoring and management","volume":"57","author":"Koster","year":"2018","journal-title":"Rheumatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/imj.13713","article-title":"The full blood count as an ancillary test to support the diagnosis of giant cell arteritis","volume":"48","author":"Oh","year":"2017","journal-title":"Intern Med J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1038\/s41598-017-06826-4","article-title":"Involvement of monocyte subsets in the immunopathology of giant cell arteritis","volume":"7","author":"van Sleen","year":"2017","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/rheumatology\/32.8.666","article-title":"Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica\/giant cell arteritis","volume":"32","author":"Macchioni","year":"1993","journal-title":"Br J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/ard.48.4.307","article-title":"Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis","volume":"48","author":"Dasgupta","year":"1989","journal-title":"Ann Rheum Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ard.52.10.730","article-title":"Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment","volume":"52","author":"Pountain","year":"1993","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/BF02208086","article-title":"Peripheral blood lymphocyte subsets in polymyalgia rheumatica","volume":"14","author":"Uddhammar","year":"1995","journal-title":"Clin Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheumat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2009","journal-title":"Rheumatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1182\/blood-2007-10-119636","article-title":"IL6\/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice","volume":"111","author":"Walker","year":"2008","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fimmu.2016.00502","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/rheumatology\/kex169","article-title":"Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica","volume":"56","author":"Carvajal Alegria","year":"2017","journal-title":"Rheumatology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1756-185X.12537","article-title":"Frequency and causes of C-reactive protein and erythrocyte sedimentation rate disagreements in adults","volume":"18","author":"Sbong","year":"2015","journal-title":"Int J Rheumat Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/00365517909108829","article-title":"The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models","volume":"39","author":"Talstad","year":"1979","journal-title":"Scand J Clin Lab Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"B39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"Matrix metalloprotease-9 (MMP-9)-producing monocytes enable T cells to invade the vessel wall and cause vasculitis","volume":"123","author":"Watanabe Ryu","year":"2018","journal-title":"Circ Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/rheumatology\/kew001","article-title":"The role of toll like receptors in giant cell arteritis","volume":"55","author":"O'neill","year":"2016","journal-title":"Rheumatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1136\/ard.2010.140194","article-title":"Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis","volume":"70","author":"Alvarez Rodriguez","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrrheum.2010.140","article-title":"Regulatory B cells in autoimmunity: developments and controversies","volume":"6","author":"Mauri","year":"2010","journal-title":"Nat Rev Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fimmu.2019.00083","article-title":"Massive B-cell infiltration and organization into artery tertiary lymphoid organs in the aorta of large vessel giant cell arteritis","volume":"10","author":"Graver","year":"2019","journal-title":"Front Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0002-9343(81)90363-6","article-title":"Prednisone-induced leukocytosis: influence of dosage, method and duration of administration on the degree of leukocytosis","volume":"71","author":"Shoenfeld","year":"1981","journal-title":"Am J Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s005990050029","article-title":"Methylprednisolone-induced neutrophil leukocytosis\u2014down-modulation of neutrophil L-selectin and Mac-1 expression and induction of granulocyte-colony stimulating factor","volume":"28","author":"Crockard","year":"1998","journal-title":"Int J Clin Lab Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/01.CIR.98.21.2307","article-title":"Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes","volume":"98","author":"Nakagawa","year":"1998","journal-title":"Circulation."},{"key":"B48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1189\/jlb.1202612","article-title":"Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes","volume":"74","author":"Dayyani","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/archneur.58.1.91","article-title":"High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes","volume":"58","author":"Leussink","year":"2001","journal-title":"Arch Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Care Res."},{"key":"B51","first-page":"171","article-title":"Prognostic factors and long term evolution in a cohort of 133 patients with giant cell arteritis","volume":"19","author":"Hachulla","year":"2001","journal-title":"Clin Exp Rheumatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/art.40876","article-title":"Glucocorticoid doses and acute-phase reactants at giant cell arteritis flare in a randomized trial of tocilizumab","volume":"71","author":"Stone John","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00296-018-4086-1","article-title":"Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition","volume":"38","author":"Camellino Dario","year":"2018","journal-title":"Rheumatol Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/rheumatology\/ker163","article-title":"Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis\u2014a prospective longitudinal study","volume":"50","author":"Visvanathan","year":"2011","journal-title":"Rheumatology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3899\/jrheum.141347","article-title":"Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study","volume":"42","author":"Kermani","year":"2015","journal-title":"J Rheumatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/ar3358","article-title":"Giant cell arteritis: immune and vascular aging as disease risk factors","volume":"13","author":"Mohan","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B57","first-page":"182","article-title":"Extracranial giant cell arteritis: a narrative review","volume":"74","author":"Lensen","year":"2016","journal-title":"Neth J Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/vox.12396","article-title":"Low-grade inflammation is associated with lower haemoglobin levels in healthy individuals: results from the Danish blood donor study","volume":"111","author":"Kotz\u00e9","year":"2016","journal-title":"Vox Sang."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01981\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T02:41:22Z","timestamp":1569120082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01981\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2019.01981"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01981","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"article-number":"1981"}}